We are live on
!
Find out more
N
Natixis Portfolio holdings
AUM
$28B
1-Year Est. Return
26.79%
Natixis is a global financial services business line of Groupe BPCE, offering a range of services including corporate and investment banking, asset management, insurance, and wealth management, with a focus on green and sustainable finance.
This Fund
S&P 500
This Quarter
Est. Return
+26.3%
1 Year Est. Return
+26.79%
3 Year Est. Return
+97.72%
5 Year Est. Return
+108.83%
10 Year Est. Return
+452.99%
AUM
$12.9B
AUM Growth
+$151M
(+1.2%)
Cap. Flow
-$2.53B
Cap. Flow
% of AUM
-19.61%
Top 10 Holdings %
Top 10 Hldgs %
34.42%
Holding
917
New
232
Increased
199
Reduced
245
Closed
202
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$344M |
| 2 |
Vale
VALE
|
+$168M |
| 3 |
AT&T
T
|
+$137M |
| 4 |
S&P Global
SPGI
|
+$131M |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$416M |
| 2 |
Microsoft
MSFT
|
+$406M |
| 3 |
Merck
MRK
|
+$180M |
| 4 |
Starbucks
SBUX
|
+$165M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$155M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 13.33% |
| 2 | Technology | 11.78% |
| 3 | Healthcare | 9.81% |
| 4 | Financials | 9.42% |
| 5 | Industrials | 5.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Aflac
AFL
$63.9B
| $9.08M | 0.07% |
252,048
-244,975
| -49% | -$8.85M |
|
202
Honeywell
HON
$77B
| $9.07M | 0.07% |
66,525
-191,910
| -74% | -$25.4M |
|
203
Rithm Capital
RITM
$5.09B
| $9M | 0.07% |
+1,211,000
| New | +$7.84M |
|
204
AGNC Investment
AGNC
$12.3B
| $8.94M | 0.07% |
693,302
+676,817
| +4,106% | +$8.49M |
|
|
SPLK
205
DELISTED
Splunk Inc
SPLK
| $8.82M | 0.07% |
44,388
-19,155
| -30% | -$3.03M |
|
206
Teladoc Health
TDOC
$1.58B
| $8.78M | 0.07% |
46,009
-31
| -0.1% | -$5.43K |
|
207
Biogen
BIIB
$29.9B
| $8.69M | 0.07% |
32,475
-40,786
| -56% | -$12.3M |
|
208
ConocoPhillips
COP
$147B
| $8.54M | 0.07% |
203,363
-1,025,206
| -83% | -$41.5M |
|
209
Kimco Realty
KIM
$17.6B
| $8.52M | 0.07% |
663,557
-54,598
| -8% | -$607K |
|
|
ETRN
210
DELISTED
Equitrans Midstream Corporation Common Stock
ETRN
| $8.52M | 0.07% |
+1,024,802
| New | +$8.07M |
|
|
JNPR
211
DELISTED
Juniper Networks
JNPR
| $8.5M | 0.07% |
371,897
+345,627
| +1,316% | +$7.95M |
|
212
ProShares Short VIX Short-Term Futures ETF
SVXY
$220M
| $8.5M | 0.07% |
539,720
-60,000
| -10% | -$976K |
|
213
Hormel Foods
HRL
$13.9B
| $8.42M | 0.07% |
+174,397
| New | +$8.33M |
|
|
TPTX
214
DELISTED
Turning Point Therapeutics, Inc. Common Stock
TPTX
| $8.38M | 0.07% |
+129,663
| New | +$7.48M |
|
215
CSX Corp
CSX
$98.6B
| $8.37M | 0.07% |
360,183
-245,523
| -41% | -$5.43M |
|
216
Thermo Fisher Scientific
TMO
$211B
| $8.32M | 0.06% |
22,960
-104,104
| -82% | -$34.9M |
|
217
Elanco Animal Health
ELAN
$12.4B
| $8.26M | 0.06% |
385,095
-1,474,932
| -79% | -$32.6M |
|
|
218
Merck
MRK
$324B
| $8.21M | 0.06% |
111,265
-2,390,705
| -96% | -$180M |
|
219
Franklin Resources
BEN
$16.9B
| $8.1M | 0.06% |
386,336
+125,865
| +48% | +$2.37M |
|
220
Carnival Corporation Ltd
CCL
$36.1B
| $8.08M | 0.06% |
491,992
+376,743
| +327% | +$5.65M |
|
221
Autohome
ATHM
$2.43B
| $8.01M | 0.06% |
106,094
-339,820
| -76% | -$26.6M |
|
222
Monster Beverage
MNST
$91.4B
| $7.93M | 0.06% |
228,862
+178,834
| +357% | +$5.84M |
|
|
PRAH
223
DELISTED
PRA Health Sciences, Inc.
PRAH
| $7.76M | 0.06% |
+79,800
| New | +$7.43M |
|
224
Leidos
LDOS
$14.1B
| $7.75M | 0.06% |
82,774
+6,342
| +8% | +$625K |
|
225
Qualys
QLYS
$4.84B
| $7.73M | 0.06% |
74,300
+4,941
| +7% | +$518K |
|
Similar funds
TWC
FDCDDQ
PCH
NA
Natixis's Q2 2020 Portfolio in Review
As of Q2 2020, Natixis held 917 positions worth $12.9B, up 1.2% from $12.7B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Natixis withdrew a net $2.53B in Q2 2020, closing 202 positions and reducing 245 holdings. Its most notable exit was State Street SPDR S&P Biotech ETF, an estimated $155M position sold in full.
By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 14% a quarter earlier, followed by Technology and Healthcare.
Against the trend, Natixis opened a new position in S&P Global worth $144M.
- Natixis's largest Q2 2020 buy was S&P Global: 436,534 shares worth $144M.
- Natixis added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $344M increase.
- Natixis's biggest Q2 2020 reduction was Apple, cutting an estimated $416M.
- Natixis fully exited State Street SPDR S&P Biotech ETF in Q2 2020, selling an estimated $155M.
- Natixis's ten largest holdings make up 34% of its $12.9B portfolio in Q2 2020.
- Natixis opened 232 new positions and closed 202 in Q2 2020.
- Natixis's portfolio value rose 1.2% quarter-over-quarter to $12.9B.
Based on Natixis's 13F filing for Q2 2020, filed 13 Aug 2020.